News
DCGI’s Next List of FDC’s Under Review
The Drug Controller General of India (DCGI) has listed a new set of 1200 fixed-dose combinations(FDCs) which was sent for investigation of the panel that eradicated nearly 350 drug combinations last week. FDC is a combination of more than two drugs in a single pill. According to experts various drugs
Embryonic Stem Cell could be the Cure to Male Infertility | Morulaa
From the use of embryonic stem cells, the Chinese scientists says that they have discovered the functioning sperm, that has been injected into the female mice eggs and resulted normal, fertile offspring. While the experts warned that the process needs more experiments before truing it on humans, the research may
Indian Medical Device Market – $17.6 Billion by 2020 ?
There will be a good number of impression seen with the expansion of the medical device space in India, growth of about $10.4 billion to $17.6 billion from the year 2014 to 2020 can be expected to bring a salient Annual Growth Rate(CAGR) of 9.4 percent, by the report of research and consulting
CDSCO: E-Governance’s Online Portal for Uninterrrupted Regulatory
The Central Drug Standard Control Organisation (CDSCO) has decided to initiate an online portal for Registration and import license application for the medical device. This online registration / submission of medical devices portal should start from March, in which we can apply, track the status of application, document submitted, license to
IPA Joins hands for Excellence and Quality
In India the several huge pharmaceutical companies comes under the Indian Pharmaceutical Alliance, has lead an initiative of Quality Forum (QF). Focusing terrain of the Quality Forum being Excellence and Quality, hence the Indian pharmaceutical industry’s problems regards to the regulatory to be looked in and solved. To put a stop to
Seamless Approval and Simplified Regulations for Stem Cell
The expert group from stem cell industry in order to get faster clearance, are pushing hard on the committees under the scope of the Drug Controller General of India for their products. DCGI’s final consent are Institutional Ethics Committee (IEC) or Institutional Committee for Stem Cell Research (IC-SCR) and National
Will the Indian Pharma remain muted or grow FY 17 ?
Register muted export revenue and stable domestic revenue in India to be expected to increase in the next budgetary year. 5 per cent of overall pharmaceutical exports and 8-10 per cent on domestic pharma is expected. Speaking about the exports, current PM Narendra Modi has brought up “come make in India” in which
India’s Biotech Moment in February
The fear of Zika virus infection, has not been reported in India, but the America is the first country in the world to test not just one but two vaccines against the virus that is causing nightmares. India might have not proven to be a full fledged vaccine manufacturer but
CDSCO planning to bring down the price of Hepatitis Treatment in India
12 million people are affected by Hepatitis C in India. India is one of the few countries in the world which have generics for interferon – free treatment, to help combat the disease. Also, fresh hope to patients as the Apex Committee of the Central Drugs Standard Control Organisation (CDSCO),
Medical Devices to Be Regulated Independently in this Country?
In most Asian countries including South Korea, Indonesia, Thailand, Malaysia, Philippines, Singapore and Vietnam medical devices are regulated separately from drugs. However, in India currently medical devices, drugs, IVD’s and cosmetics are all regulated under the same Drugs and Cosmetics Act. The new government under Modi is keen on delinking the medical device